Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Vadim Alexandre | Liam Gascoigne-Cohen
3 pages
Fusion Antibodies (FAB.L): FY20 Results | Verona Pharma plc (AIM: VRP.L): Second part of Phase 2 trial of ensifentrine in COPD commences
Companies: BLOK NWT IOF ECOB THR FAB BLOE ESYS STX BKS AREC
Companies: SYGGF INDVN 4BB ACSO PRM SUN AMS ARBB SN/ EKF EAH SAR TSTL IPO CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI PHP STX CREO SYNC APAX AREC ONT SLN IMCR ABDX
Companies: VARE FAB SWG HERC B90 COOK APTA AXS CTA
Companies: TXG SYGGF INDVN Z29 TXG FARN 4BB PRM SUN AMS SN/ OMG EKF EAH SAR TSTL IPO CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI PHP STX CREO SYNC AREC ONT SLN IMCR ABDX
Companies: Fusion Antibodies Plc
